Use of Cordia dichotoma bark in the treatment of ulcerative colitis

Pharmaceutical Biology

Volumn 49, Issue 8, 2011, Pages 850-855

  Ganjare, Anjali B ^a   Nirmal, Sunil A ^a   Rub, Ruksana A ^a   Patil, Anuja N ^a   Pattan, Shashikant R ^a  

^a PRAVARA RURAL COLLEGE OF PHARMACY   (India)

Author keywords

Cordia dichotoma; histopathology; malondialdehyde; myeloperoxidase; ulcerative colitis

Indexed keywords

ANTIOXIDANT; CORDIA DICHOTOMA EXTRACT; MALONALDEHYDE; MYELOPEROXIDASE; PHENOL DERIVATIVE; PLANT EXTRACT; PREDNISOLONE; TROLOX C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BARK; CONTROLLED STUDY; CORDIA; CORDIA DICHOTOMA; HEALING; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; SCORING SYSTEM; ULCERATIVE COLITIS; VALIDATION STUDY;

ANIMALS; ANTIOXIDANTS; BENZOTHIAZOLES; BIPHENYL COMPOUNDS; COLITIS, ULCERATIVE; COLON; CORDIA; FREE RADICAL SCAVENGERS; MALE; MALONDIALDEHYDE; MEDICINE, AYURVEDIC; MICE; PEROXIDASE; PHENOLS; PHYTOTHERAPY; PICRATES; PLANT BARK; PLANT EXTRACTS; SULFONIC ACIDS;

ANIMALIA; BORAGINACEAE; CORDIA DICHOTOMA;

EID: 79959607589     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2010.551539     Document Type: Article

References (27)

1. Akgun E, Caliskan C, Celik HA, Ozutemiz AO, Tuncyurek M, Aydin HH. (2005). Effects of N-acetylcysteine treatment on oxidative stress in acetic acid-induced experimental colitis in rats. J Int Med Res, 33, 196-206. (Pubitemid 40372435)
2. Anonymous. (2004). The Wealth of India, Vol. IV. Council of Scientific and Industrial Research: New Delhi, 152.
3. Ardizzone S, Bianchi Porro G. (2005). Biologic therapy for inflammatory bowel disease. Drugs, 65, 2253-2286. (Pubitemid 41571985)
4. Benzie IF, Strain JJ. (1996). The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": The FRAP assay. Anal Biochem, 239, 70-76.
5. Brand-Williams W, Cuvelier ME, Berset C. (1995). Use of a free radical method to evaluate antioxidant activity. Food Sci Technol, 28, 25-30.
6. Buege JA, Aust SD. (1978). Microsomal lipid peroxidation. Meth Enzymol, 52, 302-310.
7. Buffinton GD, Doe WF. (1995). Depleted mucosal antioxidant defences in inflammatory bowel disease. Free Radic Biol Med, 19, 911-918.
8. Cetinkaya A, Bulbuloglu E, Kurutas EB, Ciralik H, Kantarceken B, Buyukbese MA. (2005). Beneficial effects of N-acetylcysteine on acetic acid-induced colitis in rats. Tohoku J Exp Med, 206, 131-139. (Pubitemid 40895042)
9. Evans SM, László F, Whittle BJ. (2000). Site-specific lesion formation, inflammation and inducible nitric oxide synthase expression by indomethacin in the rat intestine. Eur J Pharmacol, 388, 281-285. (Pubitemid 30089853)
10. Frondoza CG, Sohrabi A, Polotsky A, Phan PV, Hungerford DS, Lindmark L. (2004). An in vitro screening assay for inhibitors of proinflammatory mediators in herbal extracts using human synoviocyte cultures. In Vitro Cell Dev Biol Anim, 40, 95-101. (Pubitemid 39096224)
11. Grzanna R, Lindmark L, Frondoza CG. (2005). Ginger-an herbal medicinal product with broad anti-inflammatory actions. J Med Food, 8, 125-132. (Pubitemid 41008974)
12. Itoh H, Kataoka H, Tomita M, Hamasuna R, Nawa Y, Kitamura N, Koono M. (2000). Upregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosa. Am J Physiol Gastrointest Liver Physiol, 278, G635-G643. (Pubitemid 30213130)
13. Kathleen A, Julie S, Jurenka. (2003). Inflammatory bowel disease Part I: Ulcerative colitis-pathophysiology and conventional and alternative treatment options. Alternative Medicine Review 8, 247-278.
14. Kirsner JB, Shorter RG. (1982). Recent developments in nonspecific inflammatory bowel disease (second of two parts). N Engl J Med, 306, 837-848. (Pubitemid 12150164)
15. Kirtikar KR, Basu BD. (1956). Indian Medicinal Plant, Second Edition, Vol. II, International Book Distributors: Deharadun pp.723.
16. Krawisz JE, Sharon P, Stenson WF. (1984). Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology, 87, 1344-1350. (Pubitemid 15201434)
17. Kruidenier L, Kuiper I, Lamers CB, Verspaget HW. (2003). Intestinal oxidative damage in inflammatory bowel disease: semiquantification, localization, and association with mucosal antioxidants. J Pathol, 201, 28-36. (Pubitemid 37121200)
18. Kruidenier L, Verspaget HW. (2002). Review article: Oxidative stress as a pathogenic factor in inflammatory bowel disease-radicals or ridiculous? Aliment Pharmacol Ther, 16, 1997-2015. (Pubitemid 36009163)
19. Mahgoub AA, El-Medany AA, Hager HH, Mustafa AA, El-Sabah DM. (2003). Evaluating the prophylactic potential of zafirlukast against the toxic effects of acetic acid on the rat colon. Toxicol Lett, 145, 79-87. (Pubitemid 38366131)
20. Nadkarni AK. (1991). Indian Materia Medica, Third Edition, Vol. I, Bombay Popular Prakashan: Bombay, pp. 1197-1198.
21. Nakamura K, Honda K, Mizutani T, Akiho H, Harada N. (2006). Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules. World J Gastroenterol, 12, 4628-4635. (Pubitemid 44269718)
22. Otani T, Yamaguchi K, Scherl E, Du B, Tai HH, Greifer M, Petrovic L, Daikoku T, Dey SK, Subbaramaiah K, Dannenberg AJ. (2006). Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: Evidence for involvement of TNF-alpha. Am J Physiol Gastrointest Liver Physiol, 290, G361-G368.
23. Ragazzi E, Veronese G. (1973). Quantitative analysis of phenolic compounds after thin-layer chromatographic separation. J Chromatogr, 77, 369-375.
24. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. (1999). Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med, 26, 1231-1237. (Pubitemid 29262709)
25. Sartor RB. (1997). Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol, 92, 5S-11S.
26. Stucchi A, Reed K, O'Brien M, Cerda S, Andrews C, Gower A, Bushell K, Amar S, Leeman S, Becker J. (2006). A new transcription factor that regulates TNF-alpha gene expression, LITAF, is increased in intestinal tissues from patients with CD and UC. Inflamm Bowel Dis, 12, 581-587. (Pubitemid 43977739)
27. Tripathi S, Maier KG, Bruch D, Kittur DS. (2007). Effect of 6-gingerol on pro-inflammatory cytokine production and costimulatory molecule expression in murine peritoneal macrophages. J Surg Res, 138, 209-213. (Pubitemid 46365725)